Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | REGN4659 |
Trade Name | |
Synonyms | REGN-4659|REGN 4659 |
Drug Descriptions |
REGN4659 is a human monoclonal antibody that targets CTLA4, potentially resulting in increased anti-tumor immune response and decreased tumor growth (Cancer Res July 1 2018 (78) (13 Supplement) 3824). |
DrugClasses | CTLA4 Antibody 31 Immune Checkpoint Inhibitor 149 |
CAS Registry Number | NA |
NCIT ID | C159764 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + REGN4659 | Cemiplimab REGN4659 | 0 | 1 |
REGN4659 | REGN4659 | 0 | 0 |